LongCovid
The authors of this publication conducted a systematic review to determine the prevalence of persistent symptoms, functional disability, or pathological changes in adults or children at least 12 weeks postinfection.
This article has recently been published by Open Forum Infesctious Diseases (Oxford University Press).
A new prospective cohort study published by Nature Medicine (Nature Portfolio) on Long COVID. From more than 1,800 adults hospitalized with Covid-19, the authors identified two distinct biomarker profiles…
A new study called COVID-OUT, carried out by researchers from the University of Minnesota, found that metformin, a safe, inexpensive and widely available drug commonly used to treat…
This morning Long COVID had a very fruitful discussion during its first exploitation workshop held by Steinbeis Europa Zentrum (Communication, dissemination and exploitation leader). During this online event, the consortium…
Statement by Dr Hans Henri P. Kluge, WHO Regional Director for Europe to the press on COVID-19, extreme heat and mpox. Statement – 36 million people across the…